How to Do Market Research for a Medical Device

Medical device market research is sized bottom-up from procedure volumes and care settings, not top-down from an industry-wide dollar figure. Run five steps — size procedure volume, map care settings, scan competitors and predicate devices, check reimbursement, and interview the people who'd actually buy or block adoption — using free public data before you spend on a paid report.

Quick Answer: Size a medical device market with five steps — procedure volume, care setting mapping, a competitor and predicate scan, a reimbursement check, and adoption-barrier interviews — built on free sources like FDA device databases, CMS claims data, and the published clinical literature, not a single top-down percentage-of-market guess.

Prerequisites: Define the Procedure, the Setting, and the User First

Define three things precisely before you pull a single number: the exact procedure or clinical workflow the device touches, the care setting or settings where it's actually used, and the person who physically operates it. Skip this step and every downstream estimate — procedure counts, competitor scans, reimbursement checks — inherits the vagueness, because you cannot look up public data for a market you haven't actually named.

"A wound care device" is not specific enough to research. "A device that debrides chronic diabetic foot ulcers in an outpatient wound care clinic, operated by a wound care nurse or podiatrist" is. The second version points you to a specific set of procedure and diagnosis codes, a specific care setting with its own reimbursement rules, and a specific buyer persona — the first version points you nowhere.

Write down three answers before moving to Step 1:

• The procedure or clinical workflow — name it precisely enough that it maps to a billing or classification code, not a general category like "cardiac" or "orthopedic."
• The care setting — inpatient hospital, ambulatory surgery center, physician office, outpatient hospital department, or home — because each has different buyers, rules, and data sources.
• The user — the specific clinical role (or, for a home-use device, the patient or caregiver) who physically operates it day to day.

If you cannot fill in all three with something concrete, you are not ready to size a market yet — you're still defining a product. That's a legitimate stage of work, but it belongs before, not during, the research below.

Step 1: Size the Market by Procedure Volume, Not by Industry Category

Size your market bottom-up from how many times the relevant procedure or clinical event actually happens, not top-down from a headline healthcare-industry dollar figure. A believable medtech market size starts with a procedure, diagnosis, or billing code, a volume estimate pulled from public claims or discharge data, and an addressable fraction you can defend line by line — not a percentage applied to a number lifted from a press release.

The mechanics are straightforward once the prerequisite work is done. Identify the procedure or diagnosis codes that match what you defined in the prerequisites step. Find a public dataset that reports volume for those codes — public claims and hospital discharge datasets, the kind cataloged in our roundup of free healthcare market data sources, publish procedure and diagnosis counts without a subscription. Then narrow that raw volume down to your actual addressable segment: the care settings your device serves, the patient population your indication covers, and the payer mix relevant to your business model.

Resist the shortcut of taking one industry report's total addressable market and multiplying it by an assumed "capture rate." Investors and grant reviewers have seen that slide enough times to distrust it on sight — it tells them nothing about whether you understand your actual buyer. A defensible bottom-up number, even a conservative or rough one, survives a follow-up question that a percentage-of-market guess never does. Show your procedure code, your source, and your math, and let the number be smaller but real.

Step 2: Map the Care Setting Landscape

Map every care setting where the procedure happens today, because site of care determines who buys your device, which regulatory and reimbursement rules apply, and how large the addressable market actually is. A device usable only in a hospital operating room serves a fundamentally smaller, differently financed market than the same procedure performed in an ambulatory surgery center, a physician's office, or a patient's home — even when the underlying clinical need is identical.

Health systems have been shifting a meaningful share of procedures out of the inpatient hospital and into lower-acuity settings for years — a widely covered trend in health policy and industry literature, though the pace and extent vary by procedure and geography. Don't assume that shift for your specific procedure without checking; confirm it with the same discharge and claims data you're already using for volume sizing.

For each setting where your procedure occurs, note who buys, what oversight applies, and how the sale actually happens:

• Inpatient hospital — capital equipment committees and value analysis boards drive purchasing; sales cycles are long and evidence-heavy.
• Ambulatory surgery center (ASC) — smaller, often physician-owned, with faster and more direct purchasing decisions.
• Outpatient hospital department — hospital-affiliated but outpatient billing and reimbursement rules, which differ from inpatient.
• Physician office — the clinician is often both user and economic decision-maker, shortening the sales cycle considerably.
• Home or patient-administered — the patient or caregiver is the user, but the payer and prescriber are usually still separate decision points.

A device that could theoretically work in any of these settings still needs one primary go-to-market setting first. Pick the one where the procedure volume, buyer accessibility, and reimbursement path line up best, and treat the others as expansion, not day-one market.

Step 3: Run a Competitor and Predicate Device Scan

Search the FDA's public device clearance and classification databases before you assume you've found an uncontested niche, because most device categories already have predicate products, and every one of them tells you something about the classification, evidence bar, and competitive crowding you're walking into. These databases are free, searchable by product code and clinical area, and list what has already been cleared or approved, how it was classified, and what predicate it was compared against.

Read the clearance summaries, not just the list of names. They typically describe the device's intended use and the basis for comparison to its predicate, which tells you how a reviewer is likely to think about your own device before you've written a single regulatory document. Supplement the FDA search with company websites and investor materials for commercial context, and a public trial registry to spot competitors who are further back in the pipeline but not yet selling.

Treat "we found no direct competitors" as a flag to investigate harder, not a reason to celebrate. It usually means one of three things: the market is genuinely too small to be worth entering, the need isn't as real as you believe, or your search wasn't broad enough — adjacent product codes and combination-product categories hide a surprising number of near-competitors. Our guide to validating a medical device startup idea walks through how to pick your own regulatory pathway once you understand the landscape; this step is only about mapping who else already occupies it.

Step 4: Check Reimbursement Before You Trust Any Demand Number

Treat every market-size estimate as provisional until you've checked reimbursement, because a large procedure volume means nothing if there is no viable way to get paid for your specific device within that procedure. Reimbursement rests on three things that all have to hold at once: an existing or attainable billing code, a payer's willingness to cover the device as medically necessary, and a payment rate high enough to support your business model.

Check each leg with public sources rather than assumption. Look up whether an existing procedure or supply code plausibly covers your device, or whether you'd need to pursue a new one — a materially longer and more expensive path. Search published payer coverage policies for the procedure to see whether comparable devices are already covered, and check public fee schedule data to see what similar codes actually pay. None of this requires a paid report; it requires knowing which public database answers which question.

Do not invent a specific reimbursement rate for your model based on what "seems reasonable." Rates change, vary by payer and geography, and are exactly the kind of number a knowledgeable reviewer will check independently. The output of this step isn't a precise revenue forecast — it's a go or no-go on whether a fundable payment path plausibly exists for the setting and code you identified in Steps 1 and 2.

Step 5: Run Adoption Barrier Interviews With the People Who'd Actually Buy or Block It

Confirm your desk research by interviewing the clinicians, economic buyers, and committees who would actually adopt or block the device, because procedure volume, reimbursement, and a clean competitive landscape can all check out on paper while a workflow, training, or storage barrier quietly kills adoption in practice. Desk research tells you a market could exist; only people tell you whether it will actually move.

Apply the same interview discipline that applies everywhere else in early validation, laid out well in Rob Fitzpatrick's The Mom Test: ask about the last time they actually did the relevant procedure and what they did instead of your not-yet-built device, not whether they'd hypothetically use something like it. Clinicians are busy and polite, and a leading "would you use this?" question reliably produces an encouraging answer that means very little. Ask about their last real case and their current workaround instead — the interview and evidence discipline covered in our complete guide to startup idea validation applies with extra force here.

Listen specifically for the barriers that never show up in claims data:

• Workflow fit — does the device add or remove steps from an already time-pressured process?
• Training and learning curve — how much retraining does adoption cost the user, and who absorbs that cost?
• Storage, sterilization, and supply chain — does it require space, equipment, or handling the setting doesn't already have?
• Capital and purchasing cycles — does it need a budget line that doesn't exist yet, or fit inside one that does?
• Switching cost from the current habit — even a genuinely better device loses to an entrenched workaround if switching feels risky.

A market that is large, reimbursed, and thinly competed can still fail if you skip this step, because none of the first four steps can see friction that only shows up once a real person tries to actually change what they do.

Public Data Sources for Medical Device Market Sizing

The five steps above draw from a small set of free, public sources. The table below maps each category to the sizing question it answers best and the caveat to apply before trusting a number pulled from it.

No single source clears every axis — coverage, granularity, and timeliness — for every question you'll ask. Triangulate instead: pair a broad, Medicare-shaped claims figure against a narrower discharge-level number, and treat any large disagreement between them as a prompt to dig deeper rather than proof that one source is simply wrong.

Mistakes: Top-Down Market Sizes Nobody Believes

The most common mistake in medtech market research is presenting a top-down number — "the global market is worth some large figure, and we only need one percent of it" — because it cannot survive a single follow-up question about where the number came from, and experienced reviewers know it on sight.

• Borrowing an industry total instead of building one. A headline market-size figure from a report you didn't produce tells a reviewer nothing about your specific procedure, setting, or addressable segment. Build your own number from procedure-level data, even if it's smaller.
• Skipping the care-setting adjustment. Applying a national procedure count to your device without adjusting for the specific settings it actually serves inflates the number and signals you haven't thought through go-to-market.
• Ignoring the predicate landscape. Claiming "no competitors" without a real database search reads as under-research, not as a discovered blue ocean — and it usually is under-research.
• Treating clearance as proof of demand. A device being cleared or approved says nothing about whether it sold, was adopted, or made money. Don't cite a competitor's clearance as evidence your market is validated.
• Citing a single source with no cross-check. Any one dataset has coverage gaps or lag. A number that only appears once, unconfirmed by a second source, is a guess wearing a citation.
• Skipping the interview step because the desk research looked clean. A tidy spreadsheet with a defensible procedure count still cannot tell you whether a real workflow or training barrier will stall adoption on the ground.

The throughline across all six: a market size only becomes believable when you can trace it back to a named procedure code, a public source, and — ideally — a conversation with someone who would actually buy or use the device.

Key Takeaways

• Size bottom-up from procedure volume, not top-down from an industry total. A defensible number starts with a procedure or diagnosis code and a public data source, not a percentage applied to a headline figure.
• Define the procedure, setting, and user before you research anything. Vague market definitions produce vague, unusable data at every step that follows.
• Care setting changes the whole market, not just the sales pitch. Buyer, regulatory bar, and reimbursement mechanism all shift with the site of care — pick a primary setting deliberately.
• A predicate and competitor scan is diligence, not busywork. Public device clearance databases reveal classification, evidence expectations, and how crowded the space really is.
• Reimbursement determines whether the market is real money or theoretical volume. Coding, coverage, and payment all have to hold — check each one with public sources before trusting a demand estimate.
• Desk research and interviews answer different questions. Public data can size a market on paper; only talking to real clinicians and buyers reveals the adoption friction that kills devices desk research can't see.
• Every number should trace back to a source you can name. If you can't point to the procedure code and dataset behind a figure, treat it as unproven until you can.

Frequently Asked Questions

How do I estimate the market size for a medical device before I have any sales data?

Estimate it bottom-up from public procedure-volume and claims data, not from an industry-wide dollar figure. Identify the relevant procedure or diagnosis code, pull volume from a public claims or discharge dataset, and narrow it to your addressable care settings and payer mix. This produces a defensible estimate with zero sales history, built entirely from free public sources.

What's the difference between medical device market research and general startup market research?

Medical device market research adds three constraints general software research doesn't have: procedure-level sizing instead of user counts, a regulatory classification and predicate landscape to map, and a reimbursement path that has to hold before any demand estimate means real revenue. The underlying discipline — public data first, interviews to confirm — is the same.

Where can I find free procedure volume data for a medical device?

Public claims data, hospital discharge datasets, and government health spending databases publish procedure and diagnosis volumes without a subscription. Our roundup of free healthcare market data sources walks through which public source answers which sizing question, including which ones cover Medicare only versus a broader population.

Do I need to hire a market research firm to size a medtech market?

Not for early-stage sizing. The public sources behind procedure volume, competitor and predicate scans, and reimbursement checks are free and accessible without a consultant. A paid research firm becomes worth considering later, when you need proprietary primary research at a scale interviews and public data can't reach — not to answer the basic sizing questions this article covers.